BioCryst Pharmaceuticals, Inc.
NasdaqGS:BCRX
$ 5.26
$-0.01 (-0.19%)
$ 5.26
$-0.01 (-0.19%)
End-of-day quote: 05/07/2024

BioCryst Pharmaceuticals financials at a glance

The revenue of BioCryst Pharmaceuticals is reported as 0.33141 billion Dollars in the fiscal year 2023. The earnings were -1 Dollars per share in 2023, which was 24.81 higher than 2022. And about -0.09731 billion Dollars are reported as free cash flow in the financials of BioCryst Pharmaceuticals 2023. No dividends were paid to the shareholders of the BioCryst Pharmaceuticals stock NasdaqGS:BCRX in the financial year 2023.

$331.41M
Revenue
$-1.00
Earnings Per Share
34.63%
Gross Margin %
$-70.86M
Free Cash Flow
Revenue
331.41
Earnings Per Share
-1.00
Gross Margin %
34.63
Free Cash Flow
-70.86

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue N/A $331.41M $270.83M $157.17M $17.81M $48.84M $20.65M $25.19M $26.35M $48.26M $13.61M $17.33M $26.29M $19.64M $63.50M $74.59M $56.56M $71.24M $6.21M $0.15M $0.34M
GM % Gross Margin % 29.07% 34.63% 4.04% -37.48% 0.00% -,127.64% 0.00% -,172.63% -,141.74% -54.70% -,281.53% -,142.58% -87.47% -,191.45% -33.40% -3.82% -28.51% -31.22% 0.00% 0.00% 0.00%
OM Operating Margin -33.81% -29.81% -54.81% -,113.08% 0.00% -,203.66% 0.00% -,227.95% -,184.45% -81.74% 0.00% -,177.24% -,122.20% -,252.44% -53.42% -18.42% -48.03% -45.31% 0.00% 0.00% 0.00%
EPS Earnings Per Share $-1.25 $-1.00 $-1.33 $-1.34 $-1.09 $-0.94 $-0.98 $-0.78 $-0.75 $-0.59 $-0.68 $-0.55 $-0.75 $-1.26 $-0.73 $-0.35 $-0.65 $-0.89 $-1.50 $-1.01 $-0.99
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% 0 0 -0.00% 0 0
Sha. Shares N/AM 206.15M 188.45M 184.66M 177.18M 154.19M 110.18M 98.61M 73.96M 73.63M 72.32M 59.38M 50.93M 46.04M 45.04M 43.96M 38.33M 38.08M 29.34M 28.98M 26.15M
OCF Operating Cash Flow N/A $-95.14M $-,161.85M $-,142.16M $-,137.22M $-89.58M $-92.57M $-41.14M $-53.44M $-13.12M $-38.55M $-26.53M $0.00M $0.00M $0.00M $0.00M $0.00M $-25.00M $0.00M $0.00M $0.00M
FCF Free Cash Flow N/A $-70.86M $-,163.20M $-,144.54M $-,164.61M $-89.93M $-92.68M $-45.31M $-60.96M $-18.24M $-38.66M $-26.56M $0.00M $0.00M $0.00M $0.00M $0.00M $-28.34M $0.00M $0.00M $0.00M
FCFS Free Cash Flow Per Share $-0.60 $-0.51 $-0.88 $-0.81 $-0.82 $-0.78 $-0.90 $-0.49 $-0.80 $-0.25 $-0.58 $-0.48 $-0.76 $-0.72 $-0.65 $-0.43 $-0.58 $-0.86 $-0.57 $-0.93 $-0.87